October 26, 2009
Cerco Medical and UC Irvine announce a new Publication: Islet transplantation using Macroencapsulation device
SAN FRANCISCO, CALIFORNIA - Cerco Medical, a privately held research company, and the University of California - Irvine have published another paper stemming from their new collaboration. The paper, "Islet transplantation using Macroencapsulation device," was presented at the October, 2009 joint meeting of the International Pancreas and Islet Transplantation Association and the International Xenotransplantation Association in Venice, Italy.
July 1, 2009
Cerco Medical Collaborates with University of California Irvine
on Diabetes Therapy
SAN FRANCISCO, CALIFORNIA - Cerco Medical has reached agreement with the University of California to sponsor research on the company's proprietary thin sheet bioartificial pancreas to treat diabetes. The University's lead researcher is Jonathan R. T. Lakey, Associate Professor and Director of Research in the Department of Surgery at the Medical School on the Irvine Campus.
Cerco Medical has invented and patented a thin alginate sheet to protect transplanted islets without immune suppression drugs. The Islet Sheet responds to changing blood sugar levels with the release of insulin in real time, mimicking the normal function of pancreatic islets. The Islet Sheet consists of live, functional islets contained within an immunologically protective coating made from a hydrogel polymer called alginate derived from kelp.
Scott King, President of Cerco Medical, commented, "We are ...... Click for entire article.
April 21, 2009
Lux Research, which provides strategic advice and on-going intelligence for emerging technologies, today published a report on Cerco Medical LLC. Their take on the Islet Sheet is that it is an unmatched 'intriguing alternative to immunosupressant regimen or microencapsulated islets' and that their clients should monitor progress for licensing opportunity.'
Scott King, President of Cerco Medical, commented "This is the first published report on Cerco Medical since we restarted research, and we are please to see that it is positive."
Click for more news.
April 8, 2009
Cerco Medical and UC Irvine announce First Publication: Biopolymer selected for bioartifical pancreas device studies
SAN FRANCISCO, CALIFORNIA - Cerco Medical, a privately held research company, and the University of California - Irvine have published their first paper stemming from their new collaboration. The paper, "Host response to alginate sheets: effect of alginate source," was presented at the March, 2009 Rachmiel Levine Diabetes Symposium sponsored by the Southern California Islet Cell Resources (SC-ICR) Center at the City of Hope.
The joint project is for the development of the Islet Sheet, an implantable device designed to deliver the metabolic advantages of islet transplantation without the use of immune suppression drugs. The Islet Sheet promises to be an important new therapy for type 1 diabetes.
The paper compares various sources of alginate, a biopolymer derived from seaweed. As the paper shows, one of the alginates made by Cerco Medical has been selected to be used in further investigations.
The funding for this research is coming from the Hanuman Medical Foundation and the UC-Irvine Department of Surgery.
September 2, 2008
Cerco Medical begins research with the University of California, Irvine
With the recent appointment of Jonathan Lakey as Director of Research in the Department of Surgury at the UC Irvine Medical Center in Orange, CA, Cerco Medical has revived research on the Islet Sheet. Click here to read more about this collaboration.
|
